What do medical sources say about Fish Oil (Omega-3) during pregnancy?

1st Trimester: ODS says it is unclear whether EPA/DHA supplements during pregnancy affect a baby's health or development; a 2024 guideline describes 600 to 1,000 mg/day of DHA plus EPA or DHA alone for people with low DHA intake or levels, starting in the second trimester, so it does not establish a first-trimester dose. Cochrane's 2018 review found fewer preterm births and low-birthweight babies but more pregnancies beyond 42 weeks, while the 2019 ORIP trial found no overall reduction in early preterm delivery. A 2026 meta-analysis reported lower preterm-birth odds, while a 2026 trial follow-up found no overall reduction in ADHD or autism diagnoses at age 10. FDA/EPA advice is about eating lower-mercury fish, not taking oil; ODS notes there is no IOM upper limit and reports general FDA advice not to exceed 5 g/day EPA+DHA from supplements, not a pregnancy dose, while a 2019 University of Brasilia study found measurable mercury in 4 of 28 oil products at levels far below those in fish. Ask your provider about your situation. 2nd Trimester: ODS says it is unclear whether EPA/DHA supplements during pregnancy affect a baby's health or development. A 2024 multi-organization guideline recommends at least 250 mg/day EPA plus DHA and an extra 100 to 200 mg/day DHA during pregnancy; for low DHA intake or levels, it describes 600 to 1,000 mg/day of DHA plus EPA or DHA alone starting in the second trimester. Cochrane's 2018 review found fewer preterm births and low-birthweight babies but more pregnancies beyond 42 weeks, while the 2019 ORIP trial found no overall reduction in early preterm delivery. A 2026 meta-analysis reported lower preterm-birth odds, although some birth-size findings changed in sensitivity analyses. FDA/EPA advice is about eating lower-mercury fish, not taking oil; ODS notes there is no IOM upper limit and reports general FDA advice not to exceed 5 g/day EPA+DHA from supplements, not a pregnancy dose, while a 2019 University of Brasilia study found measurable mercury in 4 of 28 oil products at levels far below those in fish. Ask your provider about your situation. 3rd Trimester: ODS says it is unclear whether EPA/DHA supplements during pregnancy affect a baby's health or development. Cochrane's 2018 review found fewer preterm births and low-birthweight babies but more pregnancies continuing beyond 42 weeks; a 2024 multi-organization guideline recommends extra DHA for people with low intake or levels, beginning in the second trimester and continuing to about 37 weeks. A 2026 post-hoc analysis of 761 ADORE trial participants reported that the association between 1,000 mg/day DHA and preterm or later birth differed by a gene variation; the genotype-by-dose comparison was not a planned trial aim and some groups had few early births. FDA/EPA advice is about eating lower-mercury fish, not taking oil; ODS notes there is no IOM upper limit and reports general FDA advice not to exceed 5 g/day EPA+DHA from supplements, not a pregnancy dose, while a 2019 University of Brasilia study found measurable mercury in 4 of 28 oil products at levels far below those in fish. Ask your provider about your situation.

What do medical sources say about Fish Oil (Omega-3) while breastfeeding?

ODS says human milk contains DHA but that it is unclear whether EPA/DHA supplements during breastfeeding affect a baby's health or development. In the 2025 DHANI randomized trial, 400 mg/day algal DHA from pregnancy through six months postpartum produced no major overall differences in common infant illnesses. A separate 2025 trial of 79 women found more DHA in colostrum, but not in early mature milk, and reported changes in gut bacteria rather than clinical health outcomes. A 2026 exploratory trial of 60 mother-infant pairs in India reported higher milk DHA and infant growth and development scores, but it was small, not blinded, and had no placebo. These studies do not establish a breastfeeding-specific benefit; ODS reports a general FDA maximum of 5 g/day combined EPA and DHA from supplements, not a breastfeeding dose. Ask your provider about your situation.

Where do sources disagree on Fish Oil (Omega-3) in pregnancy or breastfeeding?

Does omega-3 supplementation reduce preterm birth, and does it increase later delivery? Cochrane's 2018 review found lower preterm and early preterm birth rates and a higher chance of pregnancy continuing beyond 42 weeks. The 2026 meta-analysis also reported lower odds of preterm birth, and the 2024 clinical guideline recommends targeted higher intake for people with low DHA intake or levels. The 2019 ORIP randomized trial did not find an overall reduction in early preterm delivery with 900 mg/day omega-3. A small 2026 Brazilian trial found no group differences in its measured maternal or neonatal outcomes. ODS says it remains unclear whether EPA/DHA supplements affect a baby's health or development. The studies tested different doses, starting weeks, populations, and background omega-3 status. They also measured different outcomes: early preterm delivery is not the same outcome as any preterm birth or pregnancy beyond 42 weeks. The 2026 ADORE genotype analysis is post-hoc and based on few events in some groups, so it does not settle the overall result. Pooled trial evidence and the 2024 guideline support a possible reduction in preterm birth, especially for people with low omega-3 intake or status. The ORIP result and evidence of longer gestation show that the effects are not uniform across every population and outcome. The findings do not establish a separate effect for each trimester or a single dose for everyone.

Back to search

Fish Oil (Omega-3)

Other supplement

Also called · 12 names▾

Fish Oil, omega-3, omega-3 fatty acids, n-3 fatty acids, n-3s, fish oils, EPA, DHA, eicosapentaenoic acid, docosahexaenoic acid, marine omega-3, fish oil supplement

Omega-3 fatty acid supplement

Herbs and supplements are not FDA-approved before sale. About these sources

Capsule/tablet

Pregnancy

Cochrane's 2018 review included 70 trials and 19,927 women. It found lower preterm birth before 37 weeks (RR 0.89, 95% CI 0.81 to 0.97; 26 trials, 10,304 participants) and early preterm birth before 34 weeks (RR 0.58, 95% CI 0.44 to 0.77; 9 trials, 5,204 participants), but more pregnancies beyond 42 weeks (RR 1.61, 95% CI 1.11 to 2.33; 6 trials, 5,141 participants). In the 2019 ORIP trial, 5,544 pregnancies were randomized to 900 mg/day omega-3 or control before 20 weeks through 34 weeks; 5,486 were in the primary analysis. Early preterm delivery occurred in 2.2% versus 2.0%, with no significant difference (adjusted RR 1.13, 95% CI 0.79 to 1.63). A 2024 clinical practice guideline from multiple medical-scientific organizations recommends at least 250 mg/day EPA plus DHA from diet or supplements and an additional 100 to 200 mg/day DHA in pregnancy. For people with low DHA intake or blood levels, it describes 600 to 1,000 mg/day of DHA plus EPA or DHA alone, starting in the second trimester and no later than about 20 weeks, and continuing to about 37 weeks or birth. This is targeted clinical guidance, not a finding that every supplement or trimester has the same effect. A 2026 meta-analysis of 23 studies and 24,635 women reported lower odds of preterm birth (abstract OR 0.83, 95% CI 0.75 to 0.93); the main text gives an upper confidence limit of 0.94. Its search ended in March 2025, it rated certainty moderate for preterm birth and very low for birth-size outcomes, and sensitivity analyses removed significance for some growth outcomes. A second 2026 review included 21 DHA trials, with 19 in meta-analysis, and found no significant benefit in the assessed neurodevelopment domains; it reported a mean birth-weight difference of 72.51 g (95% CI 37.55 to 107.48) but no notable effects on other measured growth outcomes. A 2026 follow-up of a randomized trial found no overall significant reduction in ADHD or autism diagnoses at age 10; its secondary inattentive ADHD finding did not remain significant after correction for multiple testing. A 2026 secondary, post-hoc analysis of 761 ADORE trial participants compared 200 with 1,000 mg/day DHA by FADS genotype. The authors reported differing associations for early preterm and prolonged gestation, but some groups had few events and the genotype-by-dose comparison was not a prespecified trial aim. A separate 2026 Brazilian randomized trial had 45 completers and found no group differences in the maternal and neonatal outcomes it measured. A 2026 secondary analysis of the 9,461-person nuMoM2b cohort associated additional omega-3 use with lower preterm birth and small-for-gestational-age odds, but the authors cautioned about socioeconomic differences and residual confounding. FDA/EPA advice concerns eating 8 to 12 ounces of lower-mercury fish weekly, not taking an equivalent oil dose. ODS says purification removes methylmercury from omega-3 supplements. A University of Brasília laboratory analysis of 28 commercial products found quantifiable mercury in four, at 11.62 to 14.48 µg/kg; the article reported that these amounts were below the 100 µg/kg limit and lower than concentrations in fish.

Breastfeeding

ODS says breast milk contains DHA and that it is unclear whether EPA/DHA supplements during breastfeeding affect infant health or development. In the 2025 DHANI randomized trial, 957 women received 400 mg/day algal DHA or placebo from 20 weeks or earlier in pregnancy through six months postpartum. There were no major overall differences in common infant morbidity symptoms at 1, 6, or 12 months, although a small number of individual symptom comparisons differed. A 2025 randomized trial of 79 women compared DHA during the third trimester only with DHA continued to 42 days postpartum and a control group. The continued-supplement group had higher DHA in colostrum, but there was no significant difference in early mature milk; the reported infant outcomes were gut microbiome measures rather than clinical health outcomes. A 2026 exploratory lactation trial randomized 60 exclusively breastfeeding mother-infant pairs in Punjab, India to usual diet or 300 mg DHA plus 60 mg EPA daily for 150 days. The authors reported higher milk DHA and improved infant growth and development measures, but the study had 15 pairs per group, no placebo, no blinding, no formal sample-size calculation, and a low-intake regional population. The clinical evidence is therefore mixed and does not establish a general infant benefit or risk from maternal supplementation while breastfeeding.

Does omega-3 supplementation reduce preterm birth, and does it increase later delivery?

Source A says: Cochrane's 2018 review found lower preterm and early preterm birth rates and a higher chance of pregnancy continuing beyond 42 weeks. The 2026 meta-analysis also reported lower odds of preterm birth, and the 2024 clinical guideline recommends targeted higher intake for people with low DHA intake or levels. (Middleton et al.: Cochrane review, Omega-3 fatty acid addition during pregnancy, Saei Ghare Naz et al.: The Impact of Maternal Omega-3 Supplementation on Infant Anthropometric Measures and Pregnancy Outcomes, Cetin et al.: Omega-3 fatty acid supply in pregnancy for risk reduction of preterm and early preterm birth)
Source B says: The 2019 ORIP randomized trial did not find an overall reduction in early preterm delivery with 900 mg/day omega-3. A small 2026 Brazilian trial found no group differences in its measured maternal or neonatal outcomes. ODS says it remains unclear whether EPA/DHA supplements affect a baby's health or development. (Makrides et al.: A Randomized Trial of Prenatal n-3 Fatty Acid Supplementation and Preterm Delivery (ORIP), de Sousa et al.: High-DHA omega-3 supplementation in low-risk pregnant women, randomized trial, NIH Office of Dietary Supplements: Omega-3 Fatty Acids - Consumer)
Why they differ: The studies tested different doses, starting weeks, populations, and background omega-3 status. They also measured different outcomes: early preterm delivery is not the same outcome as any preterm birth or pregnancy beyond 42 weeks. The 2026 ADORE genotype analysis is post-hoc and based on few events in some groups, so it does not settle the overall result.
Other sources: A 2026 cohort analysis found an association between added omega-3 use and lower preterm-birth odds, but the authors noted socioeconomic differences and possible residual confounding. (Yakah et al.: Omega-3 supplementation in addition to prenatal vitamins and birth outcomes)
What the evidence shows overall: Pooled trial evidence and the 2024 guideline support a possible reduction in preterm birth, especially for people with low omega-3 intake or status. The ORIP result and evidence of longer gestation show that the effects are not uniform across every population and outcome. The findings do not establish a separate effect for each trimester or a single dose for everyone.

Does prenatal DHA improve a child's later cognitive or behavioral development?

Source A says: NCCIH's review of earlier trials found limited evidence of positive effects on child cognitive development, while ODS says the effect of EPA/DHA supplements on a baby's health or development remains unclear. (NCCIH: Omega-3 Supplements: What You Need To Know, NIH Office of Dietary Supplements: Omega-3 Fatty Acids - Consumer)
Source B says: The 2026 review of prenatal DHA trials found no significant benefit in the neurodevelopment domains it assessed. A 2026 randomized-trial follow-up found no overall reduction in ADHD or autism diagnoses at age 10; an inattentive ADHD finding did not remain significant after correction for multiple testing. (Xie et al.: Impact of prenatal DHA supplementation on neurodevelopment and growth, systematic review and meta-analysis, Rosenberg et al.: Fish oil-derived fatty acids during pregnancy and child neurodevelopment at age 10)
Why they differ: Studies used different DHA doses, starting points, child ages, and developmental tests. The later studies assess particular outcomes and do not show that every possible developmental effect is absent, but they do not confirm a general benefit.
What the evidence shows overall: A clear overall neurodevelopment benefit has not been established. The entry should describe the results as uncertain and should not present fish-consumption findings as proof that supplements improve child development.

Do maternal omega-3 supplements during breastfeeding improve infant health or development?

Source A says: ODS says it is unclear whether EPA/DHA supplements during breastfeeding affect a baby's health or development. In the 2025 DHANI trial, common infant illnesses showed no major overall differences between DHA and placebo groups. (NIH Office of Dietary Supplements: Omega-3 Fatty Acids - Consumer, Khandelwal et al.: DHANI randomized trial of maternal DHA and infant morbidity)
Source B says: A 2026 small, unblinded trial in Punjab, India reported higher milk DHA and better infant growth and development measures after maternal supplementation. A 2025 trial found higher DHA in colostrum with continued postpartum DHA but no significant difference in early mature milk. (Gupta et al.: Maternal DHA supplementation during lactation in Punjab, India, He et al.: DHA supplementation in pregnancy and early lactation, breast milk DHA and microbiota trial)
Why they differ: The trials enrolled different populations and used different doses, durations, and outcomes. The positive 2026 results came from a small exploratory study in a low-intake setting, while the larger DHANI trial measured common morbidity and started supplementation during pregnancy.
What the evidence shows overall: The evidence supports that maternal intake can change milk DHA levels, but it does not establish a general improvement in infant health or development. The studies are mixed and limited, so the evidence does not support a general breastfeeding-specific benefit.

Last reviewed 2026-10-16

Independent check 2026-10-16

Not yet clinician-reviewed

Ask your provider about your situation.

Algal Oil
Krill Oil
Cod Liver Oil

Fish Oil (Omega-3)

Fish Oil (Omega-3) — Breastfeeding

What the research shows

What's in it / what was tested

Sources disagree

Options sources describe

Beyond pregnancy

All sources

Related